These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24520350)

  • 1. Spatial reorganization of putaminal dopamine D2-like receptors in cranial and hand dystonia.
    Black KJ; Snyder AZ; Mink JW; Tolia VN; Revilla FJ; Moerlein SM; Perlmutter JS
    PLoS One; 2014; 9(2):e88121. PubMed ID: 24520350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased [18F]spiperone binding in putamen in idiopathic focal dystonia.
    Perlmutter JS; Stambuk MK; Markham J; Black KJ; McGee-Minnich L; Jankovic J; Moerlein SM
    J Neurosci; 1997 Jan; 17(2):843-50. PubMed ID: 8987805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased [18F]spiperone binding in putamen in dystonia.
    Perlmutter JS; Stambuk MK; Markham J; Black KJ; McGee-Minnich L; Jankovic J; Moerlein SM
    Adv Neurol; 1998; 78():161-8. PubMed ID: 9750913
    [No Abstract]   [Full Text] [Related]  

  • 4. Decreased striatal dopamine receptor binding in primary focal dystonia: a D2 or D3 defect?
    Karimi M; Moerlein SM; Videen TO; Luedtke RR; Taylor M; Mach RH; Perlmutter JS
    Mov Disord; 2011 Jan; 26(1):100-6. PubMed ID: 20960437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D2 receptor binding in dopa-responsive dystonia.
    Künig G; Leenders KL; Antonini A; Vontobel P; Weindl A; Meinck HM
    Ann Neurol; 1998 Nov; 44(5):758-62. PubMed ID: 9818931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of common dopamine D2 receptor gene polymorphisms on D2/3 receptor availability: C957T as a key determinant in putamen and ventral striatum.
    Smith CT; Dang LC; Buckholtz JW; Tetreault AM; Cowan RL; Kessler RM; Zald DH
    Transl Psychiatry; 2017 Apr; 7(4):e1091. PubMed ID: 28398340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of putaminal dopamine D2 receptors in early Parkinson's disease: a comparative PET study with [11C] raclopride and [11C]N-methylspiperone.
    Kaasinen V; Ruottinen HM; Någren K; Lehikoinen P; Oikonen V; Rinne JO
    J Nucl Med; 2000 Jan; 41(1):65-70. PubMed ID: 10647606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal striatal and thalamic dopamine neurotransmission: Genotype-related features of dystonia.
    Carbon M; Niethammer M; Peng S; Raymond D; Dhawan V; Chaly T; Ma Y; Bressman S; Eidelberg D
    Neurology; 2009 Jun; 72(24):2097-103. PubMed ID: 19528516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of dopamine D2/D3 receptor binding in patients with juvenile myoclonic epilepsy.
    Landvogt C; Buchholz HG; Bernedo V; Schreckenberger M; Werhahn KJ
    Epilepsia; 2010 Sep; 51(9):1699-706. PubMed ID: 20384765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Striatal dopamine D1-like receptor binding is unchanged in primary focal dystonia.
    Karimi M; Moerlein SM; Videen TO; Su Y; Flores HP; Perlmutter JS
    Mov Disord; 2013 Dec; 28(14):2002-6. PubMed ID: 24151192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Putaminal necrosis presenting with hemidystonia.
    Kawano H; Takeuchi Y; Misawa A; Sawada T; Imahori Y
    Pediatr Neurol; 2000 Mar; 22(3):222-4. PubMed ID: 10734254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease.
    Antonini A; Vontobel P; Psylla M; Günther I; Maguire PR; Missimer J; Leenders KL
    Arch Neurol; 1995 Dec; 52(12):1183-90. PubMed ID: 7492293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A link between synaptic plasticity and reorganization of brain activity in Parkinson's disease.
    Rebelo D; Oliveira F; Abrunhosa A; Januário C; Lemos J; Castelo-Branco M
    Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33431672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Striatal D2 receptors in symptomatic and asymptomatic carriers of dopa-responsive dystonia measured with [11C]-raclopride and positron-emission tomography.
    Kishore A; Nygaard TG; de la Fuente-Fernandez R; Naini AB; Schulzer M; Mak E; Ruth TJ; Calne DB; Snow BJ; Stoessl AJ
    Neurology; 1998 Apr; 50(4):1028-32. PubMed ID: 9566390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal [11C]-N-methyl-spiperone binding in patients with focal dystonia (torticollis) using positron emission tomography.
    Leenders K; Hartvig P; Forsgren L; Holmgren G; Almay B; Eckernäs SA; Lundqvist H; Långström B
    J Neural Transm Park Dis Dement Sect; 1993; 5(2):79-87. PubMed ID: 8101445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of dopamine D2-like receptors in postmortem CNS and pituitary: differential regional changes in schizophrenia.
    Dean B; Pavey G; Scarr E; Goeringer K; Copolov DL
    Life Sci; 2004 May; 74(25):3115-31. PubMed ID: 15081577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Striatal dopaminergic system in dopa-responsive dystonia: a multi-tracer PET study shows increased D2 receptors.
    Rinne JO; Iivanainen M; Metsähonkala L; Vainionpää L; Pääkkönen L; Någren K; Helenius H
    J Neural Transm (Vienna); 2004 Jan; 111(1):59-67. PubMed ID: 14714216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Striatal dopaminergic dysfunction at rest and during task performance in writer's cramp.
    Berman BD; Hallett M; Herscovitch P; Simonyan K
    Brain; 2013 Dec; 136(Pt 12):3645-58. PubMed ID: 24148273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of extrastriatal D2 in vivo specific binding of [¹⁸F](N-methyl)benperidol using PET.
    Eisenstein SA; Koller JM; Piccirillo M; Kim A; Antenor-Dorsey JA; Videen TO; Snyder AZ; Karimi M; Moerlein SM; Black KJ; Perlmutter JS; Hershey T
    Synapse; 2012 Sep; 66(9):770-80. PubMed ID: 22535514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased density of dopamine D2 receptors in the putamen, but not in the caudate nucleus in early Parkinson's disease: a PET study with [11C]raclopride.
    Rinne JO; Laihinen A; Ruottinen H; Ruotsalainen U; Någren K; Lehikoinen P; Oikonen V; Rinne UK
    J Neurol Sci; 1995 Oct; 132(2):156-61. PubMed ID: 8543941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.